Clinical Trial Update: Impact of the Introduction of ORKAMBI on Anxiety, Depression, Quality of Life and Adherence of Adolescents and Young Adults

View source ↗

Summary

A completed clinical trial evaluating the impact of ORKAMBI on anxiety, depression, quality of life, and medication adherence in adolescents and young adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ORKAMBI (lumacaftor and ivacaftor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | Status: COMPLETED